Gene Query: SKP1

Dataset Description Geneva Score
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 45.86
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 41.88
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 36.54
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 31.67
Sensing self and nonself circular RNAs 28.17
Role of microRNAs in the interaction between Salmonella and the host cell 26.48
MARS Seq data from human cortical organoids 25.68
RNAseq of HEK293 cells after Chtop knockdown 24.91
Co-transcriptional loading of RNA export factors shapes the human transcriptome 24.91
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 22.98
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 22.98
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 22.31
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 20.9
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 20.61
Alteration of the microRNA network during the progression of Alzheimer’s disease 20.51
Transcriptomic analysis of the HOTAIR-regulated genes 19.83
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 19.8
Next generation sequencing of small RNAs isolated from exosomes in human semen 16.93
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 16.38
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 16.15
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 16.15
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 16.09
RIG-I and MDA5 fRIP during KSHV lytic reactivation 16.07
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 15.9
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 15.87
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 14.89
Recovery and analysis of nascent RNA 14.89
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 14.89
Global analysis of enhancer targets: Mosaic-seq 14.57
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 14.2
Effect of BMP inhibition or stimulation of primary human keratinocytes 14.2
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 14.15
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 13.97
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 13.77
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 13.57
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 13.46
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 13.39
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 13.34
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 12.65
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 12.52
3’ Uridylation Expands miRNA Target Repertoire 12.49
Role of XRN2 ribonucleolytic activity in RNA metabolism 12.31
Argonaute proteins couple chromatin silencing to alternative splicing 12.27
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 12.27
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 12.2
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 11.87
Ribosomal footprinting of CN34-Parental and CN34-LM1a 11.84
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 11.76
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 11.76
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 11.03
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 11.01
CROP-Seq in Primary Human T Cells 10.94
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 10.8
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 10.78
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.73
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 10.31
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 10.28
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 10.27
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 10.08
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 10.08
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 10.07
Knockdown of ADNP in HCT116 colon cancer cells 9.98
Small-molecule targeting of brachyury transcription factor addiction in chordoma 9.97
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 9.93
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 9.83
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 9.83
Differentiation enhances Zika virus infection in neuronal brain cells 9.76
RNA-Seq with and without RNase treatment in PCa cell lines 9.74
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 9.73
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 9.73
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 9.69
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 9.63
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 9.56
Accurate annotation of human protein-coding small open reading frames 9.55
Transcriptomic analyssis following EHMT1/2 inhibition 9.53
Systematic discovery of endogenous human ribonucleoprotein complexes 9.44
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 9.44
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 9.42
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 9.42
NRDE2 negatively regulates nuclear exosome functions 9.39
DART-seq: an antibody-free method for global m6A detection 9.25
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 9.17
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 9.17
RNA m5C Methylation in breast cancer using MeRIP-Seq 9.08
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 8.98
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 8.98
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 8.87
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 8.85
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 8.85
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 8.8
Identification of renal resident macrophages across species 8.76
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 8.75
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 8.74
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 8.71
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 8.7
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 8.51
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 8.46
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 8.44
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 8.4
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 8.39
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 8.37
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 8.34
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 8.34
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 8.34
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 8.29
Exploring the RNA landscape of endothelial exosomes 8.16
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 8.11
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 8.11
Mitochondrial dsRNA triggers antiviral signalling in humans 8.1
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 8.09
Determining mRNA half-lives on a transcriptome-wide scale 8.07
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 8.07
RNA-seq of RKO cells with cTAZ KO or putback 8.04
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 8.02
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.93
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.91
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.91
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 7.9
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 7.9
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.9
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 7.87
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 7.83
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.77
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 7.77
METTL3 promotes translation in human cancer cells 7.75
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 7.74
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 7.57
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 7.56
mRNA expression in human DAOY cells 7.48
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 7.45
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 7.44
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 7.31
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 7.28
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 7.26
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 7.26
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 7.25
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 7.24
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.24
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 7.2
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 7.18
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 7.12
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 7.11
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 7.11
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 7.08
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 7.07
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.04
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 6.97
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 6.97
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 6.81
circRNA-sequencing 6.77
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 6.73
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 6.73
RNA-seq melanoma 6.72
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 6.72
Transcriptome analysis in Neobractatin treated cells 6.72
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 6.66
Profiling of escape kinetics of viruses subjected to RNAi 6.64
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 6.62
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 6.61
Triple vectors expand AAV transfer capacity in the retina 6.58
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 6.57
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 6.57
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 6.52
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 6.48
The human blood-nerve barrier transcriptome 6.46
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 6.43
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 6.38
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 6.37
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 6.37
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.33
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 6.28
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 6.19
Identification of transcription start sites for human A549 cell line using ReCappable-seq 6.15
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 6.14
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 6.14
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 6.13
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 6.06
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 6.05
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 6.02
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 6.01
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.94
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 5.9
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.89
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 5.89
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.84
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 5.82
CD95/Fas ligand mRNA is toxic to cells 5.81
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 5.76
Human cell line and subcutaneous tumor 5.71
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 5.68
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 5.66
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 5.66
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.65
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.62
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.57
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.57
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 5.55
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.51
Measure transcript integrity using RNA-seq data 5.51
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 5.49
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 5.49
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 5.49
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 5.46
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 5.44
Identification of renal resident macrophages across species [C1] 5.43
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.43
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.43
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.39
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 5.32
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 5.31
Effect of FGF13 depletion on the H460 cell line 5.19
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 5.19
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 5.18
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 5.15
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 5.13
Effect of BB608 on Gene Expression in HNSCC Cell Line 4.97
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 4.96
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 4.96
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 4.88
Transcriptome analysis of CNS leukemia 4.88
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 4.86
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 4.86
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.85
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.85
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.81
HEK293 Heat-shock experiment 4.77
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.76
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 4.76
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 4.76
Global Mapping of Human RNA-RNA Interactions 4.76
Determination of tRNA aminoacylation levels by high throughput sequencing 4.71
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 4.71
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 4.68
The transcriptome and chromatin accessbility landscape of mammalian germline 4.59
RNA-sequencing in irradiated and normal A549 cells. 4.56
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 4.49
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 4.49
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.48
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 4.37
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.37
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.37
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 4.36
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 4.32
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 4.32
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 4.31
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 4.31
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.3
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 4.3
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 4.25
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 4.23
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.22
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.22
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 4.22
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 4.22
Exogenous rescue of KLHL9 in SF210 cell line 4.19
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 4.18
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.13
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.13
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 4.08
HEXIM1 is induced by DHODH inhibition to suppress melanoma 4.01
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 4.01
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.99
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 3.97
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.96
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 3.93
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.91
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.9
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 3.87
RNAseq in Alzheimer's Disease patients 3.82
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.78
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 3.77
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 3.76
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.72
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 3.71
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 3.68
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 3.65
RNA-Seq of PRMT1 overexpression ECA109 cells 3.65
Ribosome profiling upon inhibition of eIF4A 3.62
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 3.6
mRNA expression profile of Lymphocytes 3.51
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 3.45
Aortic Valve Tissue: Stenosis vs. Sclerosis 3.43
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 3.42
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 3.42
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 3.36
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.35
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 3.33
An optimization system for isolating and sequencing of single human colon cancer cells 3.3
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.27
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 3.27
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 3.27
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 3.27
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 3.23
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 3.23
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 3.23
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.21
A single-cell transcriptome atlas of the human pancreas 3.2
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.19
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 3.18
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 3.14
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 3.1
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 3.1
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.09
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 3.06
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.02
Real-time observation of light-controlled transcription in living cells 3.0
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.99
Differential responses of human fetal brain neural stem cells to Zika virus infection 2.95
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.93
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 2.92
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 2.92
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.9
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.9
High-throughput sequencing of PROMPT-enriched samples. 2.85
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 2.82
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 2.82
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 2.77
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.76
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 2.75
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.73
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.72
Transposon-based construction of strand-specific RNA-seq libraries 2.71
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.68
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.64
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 2.62
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 2.57
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 2.56
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 2.56
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 2.53
K562 polyA RNA-Seq 2.5
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.49
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.4
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 2.4
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.4
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 2.39
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 2.36
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 2.36
Human Tfh cell RNA bulk sequencing 2.36
Global response to chemotherapy-induced apoptosis 2.35
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 2.34
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 2.32
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 2.29
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 2.23
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 2.23
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.22
Transcriptome analysis of peripheral blood monocytes 2.2
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 2.17
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 2.14
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 2.13
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 2.11
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 2.11
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.08
Differential Protein Occupancy Profiling of the mRNA Transcriptome 2.0
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 2.0
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.99
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 1.99
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.97
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.97
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.96
Dissecting neural differentiation regulatory networks through epigenetic footprinting 1.93
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.91
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.9
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.9
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.9
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.88
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.85
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.82
miR-93 Targets in Human Endothelial Cells 1.8
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 1.78
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.74
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.71
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.7
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 1.66
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 1.66
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.66
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.63
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.63
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.61
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.61
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.61
Dilated cardiomyopathy vs Myocarditis 1.6
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.59
Mapping interactions for the TNIP2 hub protein 1.59
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 1.58
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 1.54
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.52
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 1.51
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.51
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.5
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.49
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.48
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.45
Transcriptomic profile of human embryonic renal corpuscles 1.44
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 1.43
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.42
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.34
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.31
miR941 overexpression experiment 1.29
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 1.28
Comparative Analysis of Cas9 Activators Across Multiple Species 1.23
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.19
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.18
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.18
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.12
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 1.11
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.08
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.07
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.07
Transcriptome analysis upon C6orf203 silencing 1.04
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.0
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.99
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.99
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 0.97
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.97
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 0.95
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 0.94
Gene expression activation in CLL mediated by MSCs contact 0.92
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.92
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.89
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.88
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.88
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.87
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.82
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.81
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 0.8
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.77
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.77
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.76
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 0.76
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.72
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.72
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.71
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.7
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.69
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.65
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.65
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.63
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.59
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.56
High-resolution comparative analysis of great ape genomes 0.55
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.55
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.55
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.55
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.55
Differences in miRNA Detection Levels are Technology and Sequence Dependent 0.54
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 0.54
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 0.5
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 0.5
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 0.5
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.5
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.49
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.48
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.48
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.48
Transcriptomic profiling of human peripheral blood-derived mast cells 0.48
Transcriptional landscape changes during human embryonic stem cell derivation 0.46
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.42
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 0.39
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 0.39
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.38
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.35
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.34
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.33
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.33
MicroRNA-125a-5p overexpression in human macrophages 0.31
RNA-seq data 0.3
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.29
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.29
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.27
Metabolism as an early predictor of DPSCs aging 0.27
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.26
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.26
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.26
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.24
RNA-seq analysis of gene expression patterns during hESC neural differentiation 0.23
hESC neural differentiation 0.23
Gene expression alterations of pancreatic intraepithlial neoplasia 0.23
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 0.22
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.2
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.19
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.19
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.17
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 0.16
RNA-seq of primary patient AML samples 0.15
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.15
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.14
Interphase condensins regulate ligand-depedent enhancer activation 0.12
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.12
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.12
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.12
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.11
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.1
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.09
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 0.06
Role of cervicovaginal microbiota in genital inflammation 0.06
Aging-associated patterns in the expression of human endogenous retroviruses 0.05
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.05
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.05
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation